Is this you? Create Your Porfile
Avatar

Elfi Biedermann

Astellas Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Elfi Biedermann is active.

Explore More

Publication

Featured researches published by Elfi Biedermann.

Clinical Cancer Research | 2003

In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.

Katja Wosikowski; Elfi Biedermann; Benno Rattel; Norbert Breiter; Peter Jank; Roland Löser; Gerrit Jansen; Godefridus J. Peters

Bioconjugate Chemistry | 2002

Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.

Katja Riebeseel; Elfi Biedermann; Roland Löser; Norbert Breiter; Ralf Hanselmann; Rolf Mülhaupt; Clemens Unger; Felix Kratz

Archive | 1998

Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression

Elfi Biedermann; Max Hasmann; Roland Löser; Benno Rattel; Friedemann Reiter; Barbara Schein; Klaus Seibel; Klaus Vogt

Archive | 2000

Piperadinyl-substituted pyridylalkane, alkene and alkine carboxamides

Elfi Biedermann; Max Hasmann; Roland Löser; Benno Rattel; Friedemann Reiter; Barbara Schein; Klaus Seibel; Klaus Vogt; Katja Wosikowski; Isabel Schemainda

Archive | 1997

Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives

Elfi Biedermann; Max Hasmann; Roland Löser; Benno Rattel; Friedemann Reiter; Barbara Schein; Klaus Seibel; Klaus Vogt

Archive | 2000

Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy

Elfi Biedermann; Rolf Eisenburger; Max Hasmann; Roland Löser; Benno Rattel; Friedemann Reiter; Barbara Schein; Isabel Schemainda; Michael Schulz; Klaus Seibel; Klaus Vogt; Katja Wosikowski

Archive | 1997

Pyridyl alkane acid amides as cytostatics and immunosuppressives

Elfi Biedermann; Max Hasmann; Roland Löser; Benno Rattel; Friedemann Reiter; Barbara Schein; Klaus Seibel; Klaus Vogt

Archive | 2003

Use of pyridyl amides as inhibitors of angiogenesis

Elfi Biedermann; Roland Löser; Benno Rattel

Archive | 1998

Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents

Elfi Biedermann; Max Hasmann; Roland Löser; Benno Rattel; Friedemann Reiter; Barbara Schein; Klaus Seibel; Klaus Vogt; Katja Wosikowski

Archive | 1998

Piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides as cytostatics and immunesuppressants

Elfi Biedermann; Max Hasmann; Roland Löser; Benno Rattel; Friedemann Reiter; Barbara Schein; Klaus Seibel; Klaus Vogt; Katja Wosikowski

Explore More

Collaboration

Dive into the Elfi Biedermann's collaboration.

Top Co-Authors
Avatar

Benno Rattel

GPC Biotech

View shared research outputs
Top Co-Authors
Avatar

Barbara Schein

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Friedemann Reiter

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Max Hasmann

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Klaus Seibel

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Klaus Vogt

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Katja Wosikowski

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Roland Löser

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Isabel Schemainda

Astellas Pharma

View shared research outputs
Top Co-Authors
Avatar

Roland Löser

Pfizer

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge